News

Back

Patent granted to Atremorine developed by EuroEspes

Euroespes

The European Patent Office granted the patent to the Galician bioproduct Atremorine (E-PodoFavalin-15999) for the prevention and treatment of Parkinson's disease. This epinutraceutical medication was discovered and developed by a team of scientists from the International Center for Neurosciences and Genomic Medicine EuroEspes in Bergondo, led by Dr. Ramón Cacabelos.

ElCorreoGallego:https://www.elcorreogallego.es/galicia/concedida-la-patente-al-atremorine-que-desarrolla-euroespes-BA5345704#:~:text=El%20f%C3%A1rmaco%20se%20destina%20a,neurodegenerativa%2C%20en%20especial%20el%20p%C3%A1rkinson&text=La%20Oficina%20Europea%20de%20Patentes,de%20la%20enfermedad%20de%20Parkinson